Who makes Insulin dosing based on SMBG chart and education?

Insulin dosing based on SMBG chart and education is developed by Helse Stavanger HF.

What development phase is Insulin dosing based on SMBG chart and education in?

Insulin dosing based on SMBG chart and education is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Insulin dosing based on SMBG chart and education

Helse Stavanger HF · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Insulin dosing based on SMBG chart and education
Sponsor	Helse Stavanger HF
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Insulin dosing based on SMBG chart and education CI brief — competitive landscape report
Insulin dosing based on SMBG chart and education updates RSS · CI watch RSS
Helse Stavanger HF portfolio CI